C000217776 Fees and Costs — Fidelity Disruptive Medicine Fund
Data updated: 2023-08-03
The net expense ratio is 1.00%. There are no sales loads or redemption fees. In fiscal 2023 the fund paid $13K in broker commissions, 0.0265% of average net assets, and portfolio turnover was 47%.
C000217776 Fees and Expenses
Annual operating expenses and sales charges of C000217776. Prospectus, as of July 31, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 1.00% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 1.00% |
| Fee waiver | — |
| Net expense ratio | 1.00% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
C000217776 Costs Over Time
On $10,000 invested in C000217776, assuming 5% a year before costs, total costs come to $642 over 5 years, cutting the return by 1.08% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 1.00%) | $105 | $328 | $568 |
| Trading costs (broker commissions) | $3 | $9 | $15 |
| Lost growth on money paid in costs | $0 | $17 | $59 |
| Total costs | $108 | $353 | $642 |
| Value after costs | $10,392 | $11,223 | $12,121 |
| Impact on return, per year | 1.08% | 1.08% | 1.08% |
C000217776 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending May 31, 2023.
- Explicit cost rate (commissions ÷ average net assets): 0.0265%
- Total broker commissions: $13K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 47%
- Securities on loan, average value: $1.0M
- Net income from securities lending: $21K (0.042% of average net assets)
C000217776 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS GROUP INC (THE) | $2K | 16.79% |
| UBS GROUP AG | $2K | 16.23% |
| MORGAN STANLEY | $1K | 13.62% |
| CITIGROUP INC | $961 | 8.95% |
| LIQUIDNET HOLDINGS INC | $928 | 8.64% |
| BANK OF AMERICA CORPORATION | $903 | 8.41% |
| ROYAL BANK OF CANADA | $846 | 7.88% |
| CREDIT SUISSE GRP AG | $825 | 7.68% |
| JPMORGAN CHASE and CO | $662 | 6.16% |
| JEFFERIES GROUP LLC | $604 | 5.63% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.